Parse Biosciences Expands Global Reach with the South Australian Genomics Centre as Certified Service Provider
The SAGC joins Parse’s network to meet rising demand for high-quality single cell solutions in Australia
Parse Biosciences, the leader in scalable and accessible single cell sequencing, is pleased to welcome the South Australian Genomics Centre (SAGC) as the newest member of its Certified Service Provider (CSP) Program. As a certified provider, the SAGC expands access to Parse’s pioneering single cell technology, equipping researchers across Australia and the broader Asia-Pacific region with the tools and expertise to accelerate discovery at scale.
Introduced in 2024, Parse’s CSP Program was created to connect researchers with trusted service providers for outsourcing single cell projects, ranging from small-scale exploratory studies to high-throughput, routine analyses. By maintaining rigorous standards, the program ensures providers deliver high-quality, scalable solutions that drive scientific discovery forward.
“We are thrilled to be the first Genomics Centre in Australasia to partner with Parse Biosciences as a Certified Service Provider. Their single cell technology has quickly gained traction amongst the Australian research community due to its scalability, sample fixation and cost-effectiveness,” said Dr. Sen Wang, SAGC Centre Manager.
"Expanding our Certified Service Provider Program is key to ensuring researchers have reliable access to high-quality single cell sequencing solutions," said Alex Rosenberg, CEO and co-founder of Parse Biosciences. "With the SAGC joining the program, scientists now have another trusted partner equipped to support projects of all sizes with the scalability and precision they need to drive discovery."
About the South Australian Genomics Centre (SAGC)
The SAGC is located in Adelaide, South Australia with labs in both the South Australian Health and Medical Research Institute (SAHMRI) and Flinders University. The SAGC is NATA accredited and offers a wide range of genomics and bioinformatics services (e.g., RNA, WGS, WES, epigenomics, metagenomics, single cell and spatial). The SAGC supports all areas of genomics (animal, plant, environmental, microbial, and human) and clients from academia, healthcare and industry.
For more information, please visit https://sa-genomics.com.au/
About Parse Biosciences
Parse Biosciences is a global life sciences company dedicated to accelerating advancements in human health and scientific research. By empowering researchers to conduct single cell sequencing with unparalleled scale and simplicity, Parse’s innovative solutions are driving breakthroughs in cancer treatment, tissue repair, stem cell therapy, and more.
Built upon transformative technology developed at the University of Washington, Parse Biosciences has raised over $100 million and is used by over 2,500 labs worldwide. Its expanding product portfolio includes Evercode Whole Transcriptome, Evercode TCR, Evercode BCR, CRISPR Detect, Gene Select, and Trailmaker for advanced data analysis.
Headquartered in Seattle’s vibrant South Lake Union district, Parse Biosciences recently inaugurated a 34,000-square-foot facility featuring state-of-the-art laboratories to support its mission of advancing global research.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250320291525/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Lone Star Funds Announces Purchase of 175-Room Hotel in Yokohama23.4.2025 00:00:00 CEST | Press release
Lone Star Funds (“Lone Star”) announced that an affiliate of Lone Star Real Estate Fund VII, L.P. has successfully completed the purchase of a 175-room hotel in Yokohama, Japan from Singapore based real estate development, investment, capital and property management company, Mapletree Investments Pte Ltd, in a transaction advised by JLL. The hotel opened in November 2020 as part of a 1.8 million square foot mixed-use redevelopment project led by Mitsui Fudosan Co. Ltd., and occupies floors 46 through 51 in a condominium tower with over 1,176 high-end residential units. It has direct access to a subway station and is located on the waterfront of Yokohama’s Minato-Mirai submarket. Yokohama is Japan’s second largest city with 3.8 million residents and has strong demand drivers including a new central business district focused on research & development, large international meetings, incentives, conferences, and exhibitions facilities, a professional baseball team stadium, concert arenas, a
Debiopharm to Reveal Insights From Their ADC, DDR Inhibitor, and Antibody Conjugation Technology Research at the 2025 AACR Conference in Chicago22.4.2025 20:00:00 CEST | Press release
Debiopharm announces oral and poster presentations on data from their potential first-in-class compound Debio 1562M, a CD37-targeted ADC, and their best-in-class compound Debio 0123, a brain-penetrant WEE1 inhibitor. The company also announces joint poster presentation with new partner on the use of its AbYlink™ technology in preclinical setting. Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standard-of-care to cure cancer and infectious diseases and develop new antibody linker technologies, will release promising new data for two of its pipeline products at the 2025 Annual American Association for Cancer Research (AACR) meeting in Chicago, Illinois. Furthermore, a joint poster presentation with Oncodesign Services (www.oncodesign-services.com) will highlight the applicability of its antibody conjugation technology, AbYlink™, in the preparation of conjugates for use in non-invasive preclinical imaging. Comprehen
3Degrees Appoints Philippe Vedrenne as Chief Executive Officer, Effective May 1, 202522.4.2025 18:00:00 CEST | Press release
3Degrees, a leading global climate solutions provider and certified B Corporation, is pleased to announce the appointment of Philippe Vedrenne as Chief Executive Officer (CEO), effective May 1, 2025. Vedrenne is moving into the role as 3Degrees’ current CEO and co-founder Steve McDougal steps away from leadership of the company. McDougal informed the Board of Directors last year that he would be retiring as CEO; he will maintain his involvement as a member of the Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250422978066/en/ 3Degrees Appoints Philippe Vedrenne as Chief Executive Officer, Effective May 1, 2025 Vedrenne brings over two decades of global energy market experience operating across multiple continents. Most recently, at Engie, he oversaw trading and retail activities in North and South America for electricity and gas. In this position, he led efforts to bring utility-scale renewable energy solutions to the
AIT Worldwide Logistics acquires Miami-based forwarder, GSDMIA, Inc.22.4.2025 17:04:00 CEST | Press release
Strategic deal enhances trade lane support between Asia, Europe, Latin America, United States Global supply chain solutions leader AIT Worldwide Logistics has finalized an agreement to purchase the assets of GSDMIA, Inc. (“GSDMIA”), an international freight forwarder based in Miami. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250422511696/en/ The agreement to purchase GSDMIA's assets boosts AIT's specialized service expertise for the cosmetics, industrial and technology sectors. According to AIT’s Chief Development Officer, Ray Fennelly, who guided the acquisition process, GSDMIA provides deep international experience with air and ocean transportation. The team ships a diverse range of commodities between the United States, Asia, Europe and Latin America, including packaging and finished goods for the cosmetics industry, commercial HVAC equipment, and cryptocurrency data servers. “GSDMIA is an extremely dynamic group that
Kuwait’s ‘Visionary Lighthouse’ Pavilion Illuminates Expo 2025 Osaka with Innovative Design and a Future-Driven Vision22.4.2025 16:50:00 CEST | Press release
The Kuwait Pavilion at Expo 2025 Osaka, Kansai, Japan, officially opened its doors today, unveiling a spectacular architectural landmark that embodies the country’s bold vision for the future. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250422295094/en/ The Kuwait Pavilion at Expo 2025 Osaka (Photo: AETOSWire) Designed as a “Visionary Lighthouse”, the pavilion stands as a dynamic symbol of the ambitious national development plan, New Kuwait 2035, seamlessly integrating the nation’s rich heritage, innovation, and sustainability in a transformative visitor experience that engages audiences from around the world. Located in the “Empowering Lives” district, the pavilion’s design draws inspiration from Kuwait’s maritime and desert landscapes, reflecting the nation’s journey of resilience, progress, and forward-looking spirit. Kuwait’s participation in Expo 2025 Osaka highlights the continuation of a long-standing relationship
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom